Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.
Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.
<iframe src="https://statesidedaily.com/embed/cluster/223be0c89eec4daabea8a92dc73bf4f9fdb78ca6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs"></iframe>
